晚期肺癌病人接受首次免疫療法前衰弱狀況之初探

A Preliminary Study to Investigate Frailty in Advanced Lung Cancer Patients Before Receiving Immunotherapy

10.6224/JN.202012_67(6).08

陸怡安(Yi-An LU)；羅永鴻(Yung-Hung LUO)；蔡培癸(Pei-Kwei TSAY)；劉雪娥(Hsueh-Erh LIU)

晚期肺癌 ； 免疫療法 ； 衰弱 ； advanced lung cancer ； immunotherapy ； frailty

護理雜誌

67卷6期（2020 / 12 / 01）

51 - 60

繁體中文

背景：大多數晚期肺癌病人在接受免疫療法前，往往都先歷經過其他的治療。相較於接受第一線治療之晚期肺癌病人，這些病人更易出現易受傷害的傾向及衰弱的狀況。目的：本研究在探討晚期肺癌病人接受首次免疫療法前之衰弱狀況。方法：收集將接受免疫療法52位晚期肺癌病人以Fried標準判定其衰弱狀況。使用工具包括：病人基本資料、巴氏量表、美國流行病學研究中心憂鬱量表、國際身體活動量表及手握力與4.6公尺行走速度。結果：發現衰弱者占17.3%，衰弱分組會受到共病症（p = .023）、身體質量指數（p = .004）、日常體能狀態（p ＜ .001）、日常生活活動功能（p ＜ .001）及生理檢驗數值白蛋白（p = .042）、C反應蛋白（p = .048）的影響。結論／實務應用：本研究晚期肺癌病人以體重減輕與低身體活動量為衰弱的主要症狀。因此，醫療人員在病人接受免疫療法前，應評估病人的營養與身體活動功能狀況。盼藉由此研究可提供臨床照護人員思考如何在接受免疫療法之前，提供病人衰弱相關照護。

Background: Most advanced lung cancer patients have already received many types of treatment before starting immunotherapy. Compared with advanced lung cancer patients under first-line treatment, those receiving immunotherapy are vulnerable to many health problems and increased frailty. Purpose: This study was designed to investigate frailty in advanced lung cancer patients before starting immunotherapy. Methods: A total of 52 pre-immunotherapy patients completed the survey. Frailty status was determined using the Fried standard and survey questionnaires included the Barthel Index, Center for Epidemiologic Studies Depression Scale, the Chinese version of scales of international physical activities questionnaire (short version). In addition, the handgrip and 4.6-meter walk speed of the participants were measured. Result: The ratio of frailty was 17.3%, with comorbidities ( p = .023), body mass index ( p = .004), Eastern Cooperative Oncology Group Status (p ＜ .001), activities of daily living status (p ＜ .001), albumin (p = .042), and C-reactive protein (p = .048) all associated with frailty. Conclusions/Implications for Practice: In this study, weight loss and low physical activity were the main symptoms of frailty in patients with advanced lung cancer. Therefore, healthcare workers should assess the nutrition and physical activity status of patients before initiating immunotherapy. We suggest that clinical care workers provide frailty care to patients before administering immunotherapy.

1. 周美香, M.-H.,陳芬如, F.-J.,邱群芳, C.-F.,林育德, Y.-T.(2019)。高齡住院病人衰弱現況及其影響因子。榮總護理，36(1)，27-38。
   連結：
2. Brown, J. C.,Harhay, M. O.,Harhay, M. N.(2015).The prognostic importance of frailty in cancer survivors.Journal of the American Geriatrics Society,63(12),2538-2543.
3. Cawthon, P. M.,Marshall, L. M.,Michael, Y.,Dam, T.-T.,Ensrud, K. E.,Barrett-Connor, E.,Orwoll, E. S.(2007).Frailty in older men: Prevalence, progression, and relationship with mortality.Journal of the American Geriatrics Society,55(8),1216-1223.
4. Cerullo, F.,Gambassi, G.,Cesari, M.(2012).Cancer-related anemia and frailty in older persons.The Journal of Frailty & Aging,1(3),128-136.
5. Chien, C. P.,Cheng, T. A.(1985).Depression in Taiwan: Epidemiological survey utilizing CES-D.Seishin Shinkeigaku Zasshi,87(5),335-338.
6. Ethun, C. G.,Bilen, M. A.,Jani, A. B.,Maithel, S. K.,Ogan, K.,Master, V. A.(2017).Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology.CA: A Cancer Journal for Clinicians,67(5),362-377.
7. Facon, T.,Dimopoulos, M. A.,Meuleman, N.,Belch, A.,Mohty, M.,Chen, W. M.,Kim, K.,Zamagni, E.,Rodriguez-Otero, P.,Renwick, W.,Rose, C.,Tempescul, A.,Boyle, E.,Manier, S.,Attal, M.,Moreau, P.,Macro, M.,Leleu, X.,Chretien, M. L.,Mary, J. Y.(2020).A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial.Leukemia,34(1),224-233.
8. Faul, F.,Erdfelder, E.,Lang, A. G.,Buchner, A.(2007).G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences.Behavior Research Methods,39(2),175-191.
9. Fried, L. P.,Tangen, C. M.,Walston, J.,Newman, A. B.,Hirsch, C.,Gottdiener, J.,Seeman, T.,Tracy, R.,Kop, W. J.,Burke, G.,McBurnie, M. A.(2001).Frailty in older adults: Evidence for a phenotype.The Journals of Gerontology: Series A,56(3),M146-M157.
10. Green, P.,Arnold, S. V.,Cohen, D. J.,Kirtane, A. J.,Kodali, S. K.,Brown, D. L.,Rihal, C. S.,Xu, K.,Lei, Y.,Hawkey, M. C.,Kim, R. C.,Alu, M. C.,Leon, M. B.,Mack, M. J.(2015).Relation of frailty to outcomes after trans-catheter aortic valve replacement (from the PARTNER trial).TheAmerican Journal of Cardiology,116(2),264-269.
11. Haider, S.,Grabovac, I.,Dorner, T. E.(2019).Effects of physical activity interventions in frail and prefrail community-dwelling people on frailty status, muscle strength, physical performance and muscle mass-A narrative review.Wiener Klinische Wochenschrift,131(11),244-254.
12. Hanna, N.,Johnson, D.,Temin, S.,Baker, S., Jr.,Brahmer, J.,Ellis, P. M.,Giaccone, G.,Hesketh, P. J.,Jaiyesimi, I.,Leighl, N. B.,Riely, G. J.,Schiller, J. H.,Schneider, B. J.,Smith, T. J.,Tashbar, J.,Biermann, W. A.,Masters, G.(2017).Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update.Journal of Clinical Oncology,35(30),3484-3515.
13. Henchoz, Y.,Büla, C.,Guessous, I.,Santos-Eggimann, B.(2017).Association between physical frailty and quality of life in a representative sample of community-dwelling Swiss older people.The Journal of Nutrition Health and Aging,21(5),585-592.
14. Jardim, J. R.,Camelier, A.,Dal Corso, S.,Rodrigues, J. E.(2007).Strength and endurance of the respiratory and handgrip muscles after the use of flunisolide in normal subjects.Respiratory Medicine,101(7),1594-1599.
15. Jürschik, P.,Nunin, C.,Botigué, T.,Escobar, M. A.,Lavedán, A.,Viladrosa, M.(2012).Prevalence of frailty and factors associated with frailty in the elderly population of Lleida, Spain: The FRALLE survey.Archives of Gerontology and Geriatrics,55(3),625-631.
16. Mahoney, F. I.,Barthel, D. W.(1965).Function evaluation: The Barthel index.Maryland State Medical Journal,14,56-61.
17. Mello, A. C.,Engstrom, E. M.,Alves, L. C.(2014).Health-related and socio-demographic factors associated with frailty in the elderly: A systematic literature review.Cadernos de Saúde Pública,30(6),1143-1168.
18. Oken, M. M.,Creech, R. H.,Tormey, D. C.,Horton, J.,Davis, T. E.,McFadden, E. T.,Carbone, P. P.(1982).Toxicity and response criteria of the Eastern Cooperative Oncology Group.American Journal of Clinical Oncology,5(6),649-655.
19. Ørum, M.Gregersen, M.,Jensen, K.,Meldgaard, P.,Damsgaard, E. M. S.(2018).Frailty status but not age predicts complications in elderly cancer patients: A follow-up study.Acta Oncologica,57(11),1458-1466.
20. Ottenbacher, K. J.,Graham, J. E.,Al Snih, S.,Raji, M.,Samper-Ternent, R.,Ostir, G. V.,Markides, K. S.(2009).Mexican Americans and frailty: Findings from the Hispanic established populations epidemiologic studies of the elderly.American Journal of Public Health,99(4),673-679.
21. Raghavan, G.,Shaverdian, N.,Chan, S.,Chu, F. I.,Lee, P.(2018).Comparing outcomes of patients with early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy based on frailty status.Clinical Lung Cancer,19(5),E759-E766.
22. Ruiz, J.,Miller, A. A.,Tooze, J. A.,Crane, S.,Petty, W. J.,Gajra, A.,Klepin, H. D.(2019).Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.Journal of Geriatric Oncology,10(1),48-54.
23. Siegel, R. L.,Miller, K. D.,Jemal, A.(2019).Cancer statistics, 2019.CA: A Cancer Journal for Clinicians,69(1),7-34.
24. Silva, J. C.,Moraes, Z. V.,Silva. C.,Mazon, S. B.,Guariento, M. E.,Neri, A. L.,Fattori, A.(2014).Understanding red blood cell parameters in the context of the frailty phenotype: Interpretations of the FIBRA (Frailty in Brazilian Seniors) study.Archives of Gerontology and Geriatrics,59(3),636-641.
25. Wang, Y.,Zhang, R.,Shen, Y.,Su, L.,Dong, B.,Hao, Q.(2019).Prediction of chemotherapy adverse reactions and mortality in older patients with primary lung cancer through frailty index based on routine laboratory data.Clinical Interventions in Aging,14,1187-1197.
26. Woodhouse, K. W.,Wynne, H.,Baillie, S.,James, O. F. W.,Rawlins, M. D.(1988).Who are the frail elderly?.QJM: An International Journal of Medicine,68,505-506.
27. World Health Organization. (2018, May 24). The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
28. Zhang, X.,Meng, X.,Chen, Y.,Leng, S. X.,Zhang, H.(2017).The biology of aging and cancer: Frailty, inflammation, and immunity.The Cancer Journal,23(4),201-205.
29. 吳佩穎, P.-Y.,侯孟次, M.-T.,張嘉凌, C.-L.,張秦松, C.-S.,陳全裕, C.-Y.,楊宜青, Y.-C.,張家銘, C.-M.,吳至行, C.-H.(2011)。南臺灣偏遠地區老年男性衰弱盛行率及相關危險因子。台灣老年醫學暨老年學雜誌，6(3)，161-175。
30. 邱宜君, I.- C.,林宜萱, I.-H.,李庭蓁, T.-J.,胡名霞, M.-H.(2009)。使用Jamar握力器評估抓握動態耐力之再測信度。物理治療，34(6)，357-363。
31. 柯獻欽, S.-C.,鄭高珍, K.-C.(2018)。晚期非小細胞肺癌之化學治療與標靶治療。內科學誌，29(3)，143-152。
32. 張欽凱, C.-K.,郭旭格, H.-K.(2006)。衰弱症候群。長期照護雜誌，10(3)，203-206。
33. 莊艷妃, Y.-F.,宋惠娟, H.-C.,林麗萍, L.-P.(2005)。偏遠礦區老人健康狀況及健康醫療資源使用之調查研究。慈濟護理雜誌，4(1)，34-41。
34. 郭梅珍, M.-C.,陳靜敏, C.-M.,鄭綺, C.(2013)。老人老化衰弱指標臨床效度之初步測試。台灣老人保健學刊，9(2)，71-93。
35. 劉影梅, Y.-M.(2004)。國立臺灣大學=National Taiwan University。
36. 衛生福利部國民健康署（2019，12月）．中華民國106年癌症登記報告。https://www.hpa.gov.tw/Pages/ashx/File.ashx?FilePath=~/File/Attach/12235/File_13854.pdf [Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC. (2019, December). Cancer registry annual report, 2017, Taiwan. https://www.hpa.gov.tw/Pages/ashx/File.ashx?FilePath=~/File/Attach/12235/File_13854.pdf]
37. 謝昌成, C.-C.,蕭雅尤, Y.-Y.,林妙秋, M.-C.,陳碧奇, P.-C.(2010)。老人衰弱症。家庭醫學與基層醫療，25(11)，410-417。